Longevity
Aging T Cells Lose Mitochondrial Protein-Making Machinery
A new PNAS study links declining mitochondrial ribosome organization to weaker CD8 T-cell function with age, while intervention…
Section
Longevity
Longevity
From the newsroom
Stories
Longevity
Mitochondrial Plaques Add a New Layer to Alzheimer’s Biology
Researchers report mitochondrial plaques in Alzheimer’s disease models and postmortem human tissue, revealing a possible link between damaged…
Longevity
Buck Campaign Targets the Data Gap in Women’s Aging
A new Buck Institute campaign seeks to build permanent research infrastructure around ovarian biology, sex-aware aging data, and…
Longevity
An Aging Workforce Makes Workplace Design a Healthspan Issue
New aging-workforce research and federal data point to workplace design as a practical layer of healthspan infrastructure, while…
Longevity
NIA Backs New Project to Map DNA Damage in Aging Cells
A new National Institute on Aging project will combine DNA-adduct mapping, repair-pathway assays, and engineered human cell lines…
Longevity
Common Alzheimer’s Risk Genes Do Not Explain SuperAgers’ Exceptional Memory
A human genetics study found that APOE and three current Alzheimer’s polygenic-risk scores did not distinguish SuperAgers from…
Longevity
The Lino Way – From Germany to Miami
A complete cinematic narrative about healing, consciousness, transformation, intuition, and the journey behind L1noNutrition. CHILDHOOD & HEALING Long…
Longevity
FDA Clears First Human Trials for Partial Epigenetic Reprogramming Targeting Age-Related Vision Loss
The U.S. Food and Drug Administration (FDA) has officially cleared an Investigational New Drug (IND) application submitted by…
Longevity
Ten Things to Know About the First Human Trial of Retinal Cellular Reprogramming
1. Core Technology The clinical trial utilizes partial cellular reprogramming, a biological process designed to reverse the aging…